PAZMEDA-DSR
PAZMEDA-DSR is a pharmaceutical capsule formulation from SupriMeda containing Pantoprazole and sustained-release Domperidone. The product is listed in the gastrointestinal segment of the SupriMeda pharmaceutical portfolio and combines two active pharmaceutical ingredients in a single capsule dosage form.
Each capsule contains Pantoprazole 40 mg and Domperidone 30 mg (SR), as specified in the product documentation. Pantoprazole belongs to the proton pump inhibitor class, while Domperidone is a prokinetic agent. The gastro-resistant and prolonged-release characteristics stated on the packaging are important formulation identifiers for healthcare professionals, pharmacists and institutional procurement teams.
PAZMEDA-DSR is supplied in a carton containing 10 strips of 10 capsules each, giving a total pack size of 100 capsules. Its brand name, ingredient composition, strength, release characteristics and dosage form provide clear identifiers for pharmaceutical catalogues, inventory systems and product procurement records.
Everything You, Need to Know
The packaging indicates 10 × 10 capsules, equivalent to 100 capsules per carton.
PAZMEDA-DSR is available as a capsule formulation with gastro-resistant Pantoprazole and prolonged-release Domperidone, as stated on the packaging.
Each capsule contains Pantoprazole 40 mg and Domperidone 30 mg in a sustained-release formulation.